Retracting the Esophagus During AF Ablation (EsoSure)

Trial Purpose and Description

To determine the outcome and effect of implementation of Esophageal Stylet as a strategy to minimize the risk of esophageal injury during the atrial fibrillation catheter ablation procedure.

Ages: 18 - 80 years

Gender: Both


Eligibility Criteria

Inclusion Criteria:

  1. Age 18 or above for the Patient or legal representative to provide informed consent.
  2. Documented paroxysmal or persistent Atrial Fibrillation by a Cardiologist and EKG finding.
  3. The patient will undergo Atrial Fibrillation catheter ablation as a treatment plan.

Exclusion Criteria:

  1. Bleeding disorder.
  2. Dysphagia to solid and liquid or any documented esophageal masses or cancer.
  3. Esophageal varices, diverticulum, esophageal web, upper GI bleeding, or hiatal hernia.

Northeast Scientific, Inc.

Dates: 10/11/2016 - 01/31/2017

Last Updated: 10/12/2016

Study HIC#: 1511016760

Get Involved

For more information about this study, contact:
Bemen Habashi
203-737-1330
bemen.habashi@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Eric M Grubman

Principal Investigator

Sub-Investigators